GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
0
c/orforglipron·posted 1 year ago by u/quiet_moderator

the ATTAIN thing finally clicked for me and I want to write it down

Paper

Right, the oral GLP-1 question again, but with numbers this time.

I have 10 data points over 34 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 69, not week 23. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

0 up / 0 down41% upvoted7 commentsid 2b2hkh18 Mar 2025

7 comments

7 in this archive, depth 4

best — the order this archive was captured in

u/trialwatch_theoMOD4 points·1 year ago

Retitled to remove editorialising. Put the evidence in the body.

replysharereportpermalink
u/quiet_moderatorOPmod2 points·1 year ago

Stalled for 21 weeks, changed nothing, and it started moving again on week 50.

replysharereportpermalink
u/deleted_my_history2 points·1 year ago

cite ATTAIN/ACHIEVE arms specifically

replysharereportpermalink
u/muscle_cramp_mo1 point·1 year ago

This is correct. ATTAIN data is phase 3.

replysharereportpermalink
u/brigade_detector3 points·1 year ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/rasmus_petrescu3 points·1 year ago

Maintenance for 21 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.

replysharereportpermalink
u/taper_off_tabitha2 points·1 year ago

the supply conversation changes if this approves

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.